National Post

Testing program will determine how far COVID has really spread

Ottawa commits $1B for research, work on vaccine

- Ryan Tumilty

• The Trudeau government committed more than $ 1 billion to COVID-19 research Thursday, including a proposal for widespread testing to better understand the coronaviru­s that led to the pandemic and to chart a recovery course for the country.

“The better we understand this virus, its spread and its impact on different people, the better we can fight it and eventually defeat it,” Prime Minister Justin Trudeau said.

The funding includes $ 40 million to do viral sequencing to track the virus and its different strains, $ 23 million for vaccine research, $ 600 million for private sector trials of drug treatments and vaccines, $114 million to the Canadian Institutes of Health Research for research into measures that could reduce the spread, and a host of smaller initiative­s.

The government is also setting up an “immunity task force” that will do widespread blood testing to determine just how far the virus has spread.

Unlike the current testing using nose and throat swabs, this wider testing using blood samples will be able to track people who may have had the virus, but had little or no symptoms and have now recovered.

Dr. David Naylor, a former dean of medicine and president of the University of Toronto, with an extensive background in epidemiolo­gy, who also chaired the national advisory committee on SARS, is on the task force.

He said there are likely many people walking around who have fought off the virus without knowing they had it. Those people are believed to be immune and knowing how many there are can help the government make decisions on easing restrictio­ns following the national lockdown that’s been in effect to fight the pandemic.

“The level of background immunity gives us some sense of how fast we can move on easing some of these restrictio­ns,” he said. “If a lot of people are immune then this will be an easier lockdown to lift. If they aren’t we have to be a lot more careful.”

Widespread blood testing will be required to determine the prevalence of the virus. While it’s expected to take months to get a full picture, early results should give a sense of the scale of the disease, Naylor said.

“I would not be surprised if there is going to be a bit of a range within Canada. We can’t test every Canadian. We can’t test everyone everywhere, but we will test a sample across the country.”

Naylor said even when the immunity testing is completed, there will still be a need to quickly test and trace people who get sick. He said once people are out of social distancing it will be harder to test outbreaks of the virus, which is why Canada has to be prepared to move quickly.

“Immunity testing alone is not the answer, you still have to have the firefighti­ng,” he said. “As soon as we get very active intermingl­ing again then it is going to be much harder to fight the flare-ups and we have to have our ‘A’ game in testing and tracing.”

As of Thursday, Canada had tested 620,000 people for the virus and reported more than 41,500 cases, including 2,141 deaths.

Dr. Theresa Tam, Canada’s chief public health officer, said the country is doing nose and throat swabs on 20,000 people per day, but she hopes to ramp that up to 60,000, which would be a good position to deal with future outbreaks.

The final stage in dealing with the virus will be a vaccine and multiple possible vaccines are under developmen­t. Also included in Trudeau’s announceme­nt was $ 29 million to a National Research Council facility in Montreal that could be used to produce large quantities of the vaccine.

Trudeau said Canada needs the ability — inside our borders — to mass-produce vaccine.

“We will see the same kinds of pressures that we’re seeing around obtaining around the world to obtain vaccines, which is why part of the investment­s we’re making today.”

The government works with provinces to produce millions of flu vaccines every year, but the most recent public health data show only 40 per cent of Canadians bother to get a flu shot. Demand for a COVID-19 vaccine will likely be much higher.

Trudeau also announced the Canadian military would respond to calls from both Quebec and Ontario for help dealing with staff shortages and other issues in longterm care homes that have been particular­ly hit by the virus, but he cautioned more needed to be done.

“This is not a long- term solution. In Canada we should not have soldiers taking care of seniors,” he said. “We will all have to ask tough questions about how it came to this. We will all have to do more to get through this terrible situation.”

 ?? Veronica Henri / Postmedia News ?? Sandy Brown looks to see her mother, 91-year- old mother Doreen, who has tested positive for COVID-19 at Orchard Villa Retirement Residence. Thirty- one residents have died at the Pickering, Ont., long-term care
home and 100 staff and residents have tested positive for the novel coronaviru­s.
Veronica Henri / Postmedia News Sandy Brown looks to see her mother, 91-year- old mother Doreen, who has tested positive for COVID-19 at Orchard Villa Retirement Residence. Thirty- one residents have died at the Pickering, Ont., long-term care home and 100 staff and residents have tested positive for the novel coronaviru­s.
 ?? Blair Gable / Reuters ?? Prime Minister Justin Trudeau committed more than $1 billion to COVID-19 research on Thursday, with some of the cash aimed at
potential drug treatments and vaccines.
Blair Gable / Reuters Prime Minister Justin Trudeau committed more than $1 billion to COVID-19 research on Thursday, with some of the cash aimed at potential drug treatments and vaccines.

Newspapers in English

Newspapers from Canada